Drugs / mycophenol mofetil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00247494 | Apr 2005 → ? | HIV infectious disease, atherosclerosis | Academic Medical Center - University of Amsterdam | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mycophenol mofetil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00247494 ↗ |
| Known as | Cellcept | “mycophenol mofetil (MMF, Cellcept®) 500 mg BID” NCT00247494 ↗ |
| Known as | MMF | “mycophenol mofetil (MMF, Cellcept®) 500 mg BID” NCT00247494 ↗ |
| Action | Inhibit | “T-cell inhibition with MMF attenuates T-cell number” NCT00247494 ↗ |